Abstract
Purpose
Cancer and its therapies can have a significant impact on general and oral health and, therefore, cause a reduction in patients' quality of life (QoL). The study aimed to evaluate the QoL of cancer patients who use antiresorptive and anti-angiogenic medications with or without the development of medication-related osteonecrosis of the jaws (MRONJ).
Methods
Sixty-two patients diagnosed with cancer under antiresorptive therapy answered three instruments from the European Organization for Cancer Research and Treatment (EORTC). The first questionnaire (QLQ-C30) aimed to measure the overall QoL, the second (QLQ-ELD14) is a complementary module for elderly patients, and the third (QLQ-OH15) aimed to assess oral health related to QoL.
Results
The mean age of the patients was 62.19 years, and 12.9% developed MRONJ. There was no significant difference between sex and MRONJ. Among the QLQ-C30 scales, the item “role functioning (RF2)” presented a significant result (p = 0.019). Those patients without MRONJ had a better function performance both in their daily chores and in their free time. Age was not associated to MRONJ, although some concerns are common to the elderly and cancer patients. QoL related to oral health presented a significant result (p = 0.048) showing that MRONJ has a negative impact on patients’ QoL.
Conclusion
Our results showed that MRONJ has a significant impact on the general and oral QoL of cancer patients, and therefore prevention and awareness must be a priority.
Similar content being viewed by others
Data availability
All material and data related to the research are available.
Code availability
N/A.
References
Murphy J, Mannion CJ (2020) Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis. Br J Oral Maxillofac Surg 58(6):619–624. https://doi.org/10.1016/j.bjoms.2020.03.010
Nicolatou-Galitis O, Schiodt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L, Niepel D, Van den Wyngaert T (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127(2):117–135. https://doi.org/10.1016/j.oooo.2018.09.008
Raj DV, Abuzar M, Borromeo GL (2016) Bisphosphonates, healthcare professionals and oral health. Gerodontology 33(1):135–143. https://doi.org/10.1111/ger.12141
Capocci M, Romeo U, Guerra F, Mannocci A, Tenore G, Annibali S, Ottolenghi L (2017) Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study. Clin Ter 168(4):e253–e257. https://doi.org/10.7417/T.2017.2015
Di Fede O, Panzarella V, Mauceri R, Fusco V, Bedogni A, Lo Muzio L, Sipmo Onj B, Campisi G (2018) The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention. Biomed Res Int 2018:2684924. https://doi.org/10.1155/2018/2684924
Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O (2017) Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 10:CD012432. https://doi.org/10.1002/14651858.CD012432.pub2
Sturrock A, Preshaw PM, Hayes C, Wilkes S (2019) General dental practitioners’ perceptions of, and attitudes towards, improving patient safety through a multidisciplinary approach to the prevention of medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in the North East of England. BMJ Open 9(6):e029951. https://doi.org/10.1136/bmjopen-2019-029951
Schmidt H, Nordhausen T, Boese S, Vordermark D, Wheelwright S, Wienke A, Johnson CD (2018) Factors influencing global health related quality of life in elderly cancer patients: results of a secondary data analysis. Geriatrics (Basel) 3(1). https://doi.org/10.3390/geriatrics3010005
Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist 16(1):121–132. https://doi.org/10.1634/theoncologist.2010-0183
Valdez JA, Brennan MT (2018) Impact of oral cancer on quality of life. Dent Clin N Am 62(1):143–154. https://doi.org/10.1016/j.cden.2017.09.001
Moore KA, Ford PJ, Farah CS (2014) Support needs and quality of life in oral cancer: a systematic review. Int J Dent Hyg 12(1):36–47. https://doi.org/10.1111/idh.12051
Saxena S, Orley J, Group W (1997) Quality of life assessment: the world health organization perspective. Eur Psychiatry 12(Suppl 3):263s–266s. https://doi.org/10.1016/S0924-9338(97)89095-5
Nayfield SG, Ganz PA, Moinpour CM, Cella DF, Hailey BJ (1992) Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1(3):203–210. https://doi.org/10.1007/BF00635619
Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, Nicolatou-Galitis O, Pinto M, Raber-Durlacher J, Singer S, Tomaszewska IM, Tomaszewski KA, Verdonck-de Leeuw I, Yarom N, Winstanley JB, Herlofson BB, Group EQ (2016) International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. Support Care Cancer 24(9):3915–3924. https://doi.org/10.1007/s00520-016-3216-0
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F, Association of O, Maxillofacial S (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Tenore G, Mohsen A, Rossi AF, Palaia G, Rocchetti F, Cassoni A, Valentini V, Ottolenghi L, Polimeni A, Romeo U (2020) Does medication-related osteonecrosis of the jaw influence the quality of life of cancer patients? Biomedicines 8(4). https://doi.org/10.3390/biomedicines8040095
McGowan K, McGowan T, Ivanovski S (2018) Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis 24(4):527–536. https://doi.org/10.1111/odi.12708
Wrazen W, Golec EB, Tomaszewska IM, Walocha E, Dudkiewicz Z, Tomaszewski KA (2014) Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14). Folia Med Cracov 54(2):35–45
Gorges J, Wehler B, Kruger M, Singer S (2018) Oral health-related quality of life in cancer patients. Laryngorhinootologie 97(5):327–333. https://doi.org/10.1055/a-0573-9741
INCA (2019) Estimate 2020: incidence of cancer in Brazil. National Cancer Institute José Alencar Gomes da Silva. https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Accessed 30 Nov 2020
Early Breast Cancer Trialists’ Collaborative G (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 386(10001):1353–1361. https://doi.org/10.1016/S0140-6736(15)60908-4
van der Poel MW, Oerlemans S, Schouten HC, van de Poll-Franse LV (2015) Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol 94(4):651–661. https://doi.org/10.1007/s00277-014-2264-0
Vanleerberghe P, De Witte N, Claes C, Schalock RL, Verte D (2017) The quality of life of older people aging in place: a literature review. Qual Life Res 26(11):2899–2907. https://doi.org/10.1007/s11136-017-1651-0
Goo AJ, Shin DW, Yang HK, Park JH, Kim SY, Shin JY, Kim YA, Kim C, Hong NS, Min YJ, Park K (2017) Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer. J Geriatr Oncol 8(4):271–276. https://doi.org/10.1016/j.jgo.2017.03.001
Petrovic I, Rosen EB, Matros E, Huryn JM, Shah JP (2018) Oral rehabilitation of the cancer patient: a formidable challenge. J Surg Oncol 117(8):1729–1735. https://doi.org/10.1002/jso.25075
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376. https://doi.org/10.1093/jnci/85.5.365
Sturrock A, Preshaw PM, Hayes C, Wilkes S (2019) Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England. BMJ Open 9(3):e024376. https://doi.org/10.1136/bmjopen-2018-024376
Haviv Y, Geller Z, Mazor S, Sharav Y, Keshet N, Zadik Y (2021) Pain characteristics in medication-related osteonecrosis of the jaws. Support Care Cancer 29(2):1073–1080. https://doi.org/10.1007/s00520-020-05600-z
Rogers SN, Semple C, Babb M, Humphris G (2016) Quality of life considerations in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 130(S2):S49–S52. https://doi.org/10.1017/S0022215116000438
Funding
This study was supported by resources from CAPES – Coordination of Higher Education Improvement.
Author information
Authors and Affiliations
Contributions
S.C. Tornier was responsible for data collection, results analysis, and writing of the manuscript; F.J. Macedo was responsible for data collection and results analysis; L.M. Sassi was responsible for study design, conceptual idea, and revision of the manuscript; J.L. Schussel was responsible for study design, conceptual idea, and writing and revision of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Research Ethics Committee of the Erasto Gaertner Cancer Center on registration 65123116.1.0000.0098 and indexed in the national database of records involving research in human beings.
Consent to participate
All participants signed an informed consent form before participating in the study.
Consent for publication
The manuscript has been seen and approved by all authors, and the material was not previously published.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Cassia Tornier, S., Macedo, F.J., Sassi, L.M. et al. Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw. Support Care Cancer 29, 6713–6719 (2021). https://doi.org/10.1007/s00520-021-06275-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06275-w